Kyverna Therapeutics, Inc. (KYTX) Net income 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$161.3MFY2025 · since FY2023: -$60.4M → -$161.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$161.3M | -26.5% |
| FY2024 | -$127.5M | -111.2% |
| FY2023 | -$60.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice